We would love to hear your thoughts about our site and services, please take our survey here.
Share buy back? I have no idea seriously
Strictly, that statement of capital has reduced by £60m since the previous filing, why would this be?
Lots of filing on Companies House today,,, RNS tomorrow?
https://find-and-update.company-information.service.gov.uk/company/07514939/filing-history
Yes Si, it says. dependant upon the court confirmation, but the hearing is on time today so no delays so far, very positive in my book, good luck orphans :)
By the timeline in the circular, if approved by the beak today then the reduction in capital will take place on the 20th,,,, so all is on track and no delays which is super positive. I'd expect an announcement between today and the 20th?
Deputy ICC Judge Frith 10:30am Remotely via MS Teams Final reductions CR-2021-000673 Open Orphan PLC
https://www.gov.uk/government/publications/business-and-property-courts-rolls-building-cause-list/business-and-property-courts-of-england-and-wales-cause-list
HL just dropped in
Eskers doing what he does best,,, standby folks,,,
https://twitter.com/eskers1/status/1393199639587917828?s=21
They stated within 5 days of allocation
I asked for 10k and was allocated 3750
Start date April,,, I believe this has not been RNS'd yet?
29 April,,, get buying people
The cut of date is unknown at present, so no FOMO effect
Looks like the start of new Covid contracts, should be RNS'd?
Do you work for Fincap?
You wouldn't want to be out of this over a long weekend :) Good Luck Orphans
Even with the exponential SP raises with these guys selling, can you imagine the potential here when they are finally out!! Begone invesco and let us fly!!
I'm not deramping anything you stroker, I'm invested here so sod off, 55 park lane DYOR
Accustem is registered to a rented apartment on Park Lane? RNS was deliberately misleading directing information to a one page website with no information for investors (other than a rented apartment address), odds on receiving a shares with a price against it in Q2 2021, probably zero.
It’s in the Times Irish section:
Speculation is mounting that Open Orphan, a clinical trial company headed by Irish dealmaker Cathal Friel, will move to spin off its stake in vaccine developer Imutex via a Nasdaq listing this year.
Through its hVivo subsidiary, Open Orphan holds a 49 per cent stake in Imutex, which develops vaccines for influenza and mosquito-borne diseases.
A number of shareholder bulletin boards are predicting that Open Orphan and Seek Group, its joint venture partner at Imutex, will look to cash in on the greater interest in vaccine development from the Covid-19 pandemic.
In a recent shareholder presentation, Open Orphan said it was “optimistic” of the potential to monetise Imutex’s inoculation development assets.
It said the business was poised to hold discussions with the US Food and Drug Administration and the European Medicines Agency on its influenza vaccine, with a view to gaining insights into areas of interest for potential partners.
There has also been speculation that Open Orphan may look to monetise other non-core assets including a 63 per cent stake in Prep Biopharm, which is developing a pan-viral prophylactic. The prophylactic mimics a number of respiratory viruses to help stimulate immunity. hVivo also has a third development asset which it hopes will counter severe influenza.
The disposal of the assets in development will allow Open Orphan to focus on its core clinical trials operations: hVivo, which is conducting a number of a viral challenges studies including tests on coronavirus vaccines, and Venn Life Sciences.
Open Orphan shares are up fivefold in the past year.